Biotech / Cell Therapy Funding

Sector profile · 1 tracked rounds · $35 million tracked capital

Capvizr tracks Biotech / Cell Therapy funding activity across newly funded companies, lead investors, hiring signals, and market narratives.

Top company Allotera TherapeuticsLargest round $35 million1 deals

Recent Biotech / Cell Therapy rounds

Allotera Therapeutics · $35 million · Series C · July 8, 2026

Market context

Biotech / Cell Therapy deal flow is monitored for capital concentration, mega-rounds, and hiring expansion.

Open Biotech / Cell Therapy in the interactive Capvizr dashboard →

Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime